LQDA Liquidia Corporation

NASDAQ
$68.66

Liquidia Corporation (LQDA) is expected to report earnings on November 11, 2026, before the market open. The consensus earnings estimate is $0.82 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -17.9% since its last earnings release on August 12, 2026.

Liquidia Missed Expectations
Wednesday, August 12, 2026 · 6:30 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 11
Wednesday · 6:30 AM ET
Earnings Whisper
-
vs $0.82
Rev est $163.09M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $72.45

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Liquidia Corporation

Liquidia Corporation is a biopharmaceutical company. It develops, manufactures and commercializes products for unmet patient needs principally in the United States. Liquidia Corporation, formerly known as LIQUIDIA TECHNL, is based in Morrisville, North Carolina.

Sector

Healthcare

Industry

Biotechnology